All Comparisons/ScreenPoint Medical vs CARPL.ai

VNDRIQ — Vendor Comparison

ScreenPoint Medical vs CARPL.ai

Side-by-side comparison of BAA status, PHI exposure, AI training risk, HIPAA suitability, and VNDRIQ governance scores.

ScreenPoint Medical63
CARPL.ai82

ScreenPoint Medical

Medical Imaging AI

Verification pending

CARPL.ai

Medical Imaging AI

Last verified: August 31, 2026

VNDRIQ Scores

63

Overall

Privacy Score43
Governance Score85
Healthcare Readiness69
AI Risk Score55

82

Overall

Privacy Score68
Governance Score85
Healthcare Readiness83
AI Risk Score90

Approval Tier

Approved
Approved

BAA Status

Available for clinical deployments in the United States.
Available upon request

PHI Exposure Risk

High
Medium

AI Training Risk

Medium
Low

HIPAA Risk Level

Medium
Low

Review Frequency

Quarterly

Quarterly

Recommended Use

Clinical decision support for radiologists during the interpretation of screening mammograms and digital breast tomosynthesis (3D mammography).

Orchestration and deployment of FDA-cleared third-party radiology AI applications within clinical workflows.

Restrictions

Must be used as a concurrent or second reader by qualified radiologists; not intended for autonomous diagnostic action.

Only integrates third-party AI models that have received their own independent FDA clearance.

Executive Summary

ScreenPoint Medical

Medical Imaging AI

ScreenPoint Medical is classified as Approved with a BAA status of Available for clinical deployments in the United States.. PHI exposure is rated High and AI training risk is Medium. Clinical decision support for radiologists during the interpretation of screening mammograms and digital breast tomosynthesis (3D mammography).

43

Privacy

85

Governance

69

Healthcare

55

AI Risk

CARPL.ai

Medical Imaging AI

CARPL.ai is classified as Approved with a BAA status of Available upon request. PHI exposure is rated Medium and AI training risk is Low. Orchestration and deployment of FDA-cleared third-party radiology AI applications within clinical workflows.

68

Privacy

85

Governance

83

Healthcare

90

AI Risk

Recommended For

ScreenPoint Medical

Clinical decision support for radiologists during the interpretation of screening mammograms and digital breast tomosynthesis (3D mammography).

Organizations with established governance workflows

Multi-location healthcare groups needing standardized vendor status

CARPL.ai

Orchestration and deployment of FDA-cleared third-party radiology AI applications within clinical workflows.

Organizations with established governance workflows

Multi-location healthcare groups needing standardized vendor status

Governance Considerations

ScreenPoint Medical

PHI exposure is elevated. Review data flow documentation.

Quarterly reviews are required — establish internal review cadence.

Restrictions noted: Must be used as a concurrent or second reader by qualified radiologists; not intended for autonomous diagnostic action.

CARPL.ai

Quarterly reviews are required — establish internal review cadence.

Restrictions noted: Only integrates third-party AI models that have received their own independent FDA clearance.

Questions to Ask Before Approval

01

Has the vendor executed a Business Associate Agreement (BAA) with your organization?

02

Does the vendor use customer data to train AI models? Can you opt out?

03

Where is PHI stored, processed, and transmitted?

04

What data retention and deletion policies apply to your PHI?

05

Has the vendor undergone a third-party HIPAA or SOC 2 audit?

06

What is the vendor's incident response and breach notification process?

07

Does the vendor offer audit logging for PHI access?

08

What subprocessors have access to PHI through this vendor?

Request Vendor Evaluation

Get a structured risk assessment for any vendor.

Request Benchmark Report

Compare vendors across your full stack.

Book Governance Assessment

Talk to a VNDRIQ governance specialist.